Agilent Technologies's total inventories for the quarter that ended in Jan. 2024 was $1,033 Mil. Agilent Technologies's average total inventories from the quarter that ended in Oct. 2023 to the quarter that ended in Jan. 2024 was $1,032 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Agilent Technologies's Net-Net Working Capital per share for the quarter that ended in Jan. 2024 was $-5.20.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Agilent Technologies's Days Inventory for the
three
months ended in Jan. 2024 was 125.56.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Agilent Technologies's Inventory Turnover for the quarter that ended in Jan. 2024 was 0.73.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Agilent Technologies's Inventory-to-Revenue for the quarter that ended in Jan. 2024 was 0.62.
Agilent Technologies Total Inventories Historical Data
The historical data trend for Agilent Technologies's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Agilent Technologies (NYSE:A) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Agilent Technologies's Net-Net Working Capital Per Share for the quarter that ended in Jan. 2024 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Agilent Technologies's Inventory to Revenue for the quarter that ended in Jan. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Agilent Technologies Total Inventories Related Terms
Thank you for viewing the detailed overview of Agilent Technologies's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.
Agilent Technologies (Agilent Technologies) Business Description
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
A has been successfully added to your 